The Leibniz Institute of Virology (LIV) conducts cutting-edge research on human-pathogenic viruses. Our research focuses on viruses that are currently of great medical relevance as well as on newly emerging viruses that may pose future challenges to human health. The aim of our research is to understand virus-related diseases and to develop new approaches to treatment and prevention. In doing so, the LIV is at the forefront of modern biomedical basic research.
The institute actively promotes the translation of basic research into practical solutions. Scientific discoveries are transformed into innovative applications through collaborations with partners, and findings are protected and leveraged, as illustrated by numerous active patents.
Moreover, the institute is equipped with state-of-the-art technology platforms, including systemic cryo-electron microscopy (EM), environmental scanning EM, FACS-based cell analysis and sorting, high-throughput deep sequencing, and high-containment BSL-3 laboratories. In addition, the institute’s infrastructure is further supported by the Scientific Computing Unit, which provides high-performance computing resources and expertise to advance data-driven virus research.
The LIV is particularly committed to nurturing the next generation of scientists. Three laboratory areas are dedicated to junior research groups, and the LIV Graduate School offers an interdisciplinary, structured PhD program. This program provides doctoral students with comprehensive training, including seminars, methodological workshops, and networking opportunities, preparing them for successful careers in infection and virology research.
